{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:01:08Z","timestamp":1793037668358,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15197-3","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:30:54Z","timestamp":1767000654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic value of peripheral blood inflammatory indices for breast cancer grade and immunohistochemical markers: a retrospective observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Nahid","family":"Nafissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Kheradpishe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Radkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Bayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh Shateri","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Hasheminezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"3","key":"15197_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"10439","key":"15197_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(24)00747-5","volume":"403","author":"CE Coles","year":"2024","unstructured":"Coles CE, Earl H, Anderson BO, Barrios CH, Bienz M, Bliss JM, et al. The lancet breast cancer commission. Lancet. 2024;403(10439):1895\u2013950.","journal-title":"Lancet"},{"key":"15197_CR3","doi-asserted-by":"publisher","first-page":"101537","DOI":"10.1016\/j.cegh.2024.101537","volume":"26","author":"Z Sanaat","year":"2024","unstructured":"Sanaat Z, Dolatkhah R. Epidemiologic profile of breast cancer in iran: a systematic review and meta-analysis. Clin Epidemiol Global Health. 2024;26:101537.","journal-title":"Clin Epidemiol Global Health"},{"issue":"1","key":"15197_CR4","doi-asserted-by":"publisher","first-page":"24431","DOI":"10.1038\/s41598-024-74608-w","volume":"14","author":"X Wu","year":"2024","unstructured":"Wu X, Zhang W, Lu X, Zhong X, Bu H. Prognostic significance of ER-to-PR difference in ER+\/HER2-early breast cancer. Sci Rep. 2024;14(1):24431.","journal-title":"Sci Rep"},{"issue":"1","key":"15197_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13058-021-01393-z","volume":"23","author":"ALV Johansson","year":"2021","unstructured":"Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G. In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study. Breast Cancer Res. 2021;23(1):17.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"15197_CR6","first-page":"40","volume":"47","author":"SH Jafari","year":"2022","unstructured":"Jafari SH, Jahanmir A, Bahramvand Y, Tahmasebi S, Dallaki M, Nasrollahi E. Association of Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression with breast cancer metastasis in Iran. Iran J Med Sci. 2022;47(1):40.","journal-title":"Iran J Med Sci"},{"issue":"3","key":"15197_CR7","doi-asserted-by":"publisher","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","volume":"103","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI, Obeagu GU. Breast cancer: A review of risk factors and diagnosis. Medicine. 2024;103(3):e36905.","journal-title":"Medicine"},{"issue":"10","key":"15197_CR8","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/cancers12102767","volume":"12","author":"J Li","year":"2020","unstructured":"Li J, Guan X, Fan Z, Ching L-M, Li Y, Wang X, et al. Non-invasive biomarkers for early detection of breast cancer. Cancers. 2020;12(10):2767.","journal-title":"Cancers"},{"issue":"6","key":"15197_CR9","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3390\/ijms26062541","volume":"26","author":"IF Faur","year":"2025","unstructured":"Faur IF, Dobrescu A, Clim IA, Pasca P, Burta C, Tarta C, et al. Prognostic significance of peripheral blood parameters as predictor of neoadjuvant chemotherapy response in breast cancer. Int J Mol Sci. 2025;26(6):2541.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"15197_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Therapy. 2021;6(1):263.","journal-title":"Signal Transduct Target Therapy"},{"key":"15197_CR11","unstructured":"Wu J, Wu XD, Gao Y. Correlation between preoperative systemic immune-inflammatory indexes and the prognosis of gastric cancer patients.\u00a0Eur Rev Med Pharmacol Sci. 2023;27(12)."},{"issue":"1","key":"15197_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12876-025-03681-w","volume":"25","author":"M Rezazadeh","year":"2025","unstructured":"Rezazadeh M, Kamyabi A, Pisheh RG, Noroozie S, Amiri BS, Negahi A, et al. Diagnostic value of peripheral blood inflammatory indices for clinicopathological profile of colorectal cancer: a retrospective observational study. BMC Gastroenterol. 2025;25(1):127.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"15197_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/medicina58081069","volume":"58","author":"H Platini","year":"2022","unstructured":"Platini H, Ferdinand E, Kohar K, Prayogo SA, Amirah S, Komariah M, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: a systematic review and meta-analysis. Medicina. 2022;58(8):1069.","journal-title":"Medicina"},{"issue":"12","key":"15197_CR14","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/medicina59122124","volume":"59","author":"D Coradduzza","year":"2023","unstructured":"Coradduzza D, Medici S, Chessa C, Zinellu A, Madonia M, Angius A, et al. Assessing the predictive power of the hemoglobin\/red cell distribution width ratio in cancer: a systematic review and future directions. Medicina. 2023;59(12):2124.","journal-title":"Medicina"},{"issue":"48","key":"15197_CR15","doi-asserted-by":"publisher","first-page":"e36315","DOI":"10.1097\/MD.0000000000036315","volume":"102","author":"J Xie","year":"2023","unstructured":"Xie J, Guo Z, Zhu Y, Ma M, Jia G. Peripheral blood inflammatory indexes in breast cancer: A review. Medicine. 2023;102(48):e36315.","journal-title":"Medicine"},{"key":"15197_CR16","doi-asserted-by":"publisher","first-page":"e17382","DOI":"10.7717\/peerj.17382","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhuang J, Wang S, Wu Y, Chen L. The prognostic value of preoperative neoindices consisting of lymphocytes, neutrophils and albumin (LANR) in operable breast cancer: a retrospective study. PeerJ. 2024;12:e17382.","journal-title":"PeerJ"},{"issue":"48","key":"15197_CR17","doi-asserted-by":"publisher","first-page":"e36315","DOI":"10.1097\/MD.0000000000036315","volume":"102","author":"J Xie","year":"2023","unstructured":"Xie J, Guo Z, Zhu Y, Ma M, Jia G. Peripheral blood inflammatory indexes in breast cancer: A review. Med (Baltim). 2023;102(48):e36315.","journal-title":"Med (Baltim)"},{"key":"15197_CR18","unstructured":"Elyasinia F, Keramati MR, Ahmadi F, Rezaei S, Ashouri M, Parsaei R, et al. Neutrophil-lymphocyte ratio in different stages of breast cancer. Acta Medica Iranica. 2017:228-32."},{"key":"15197_CR19","doi-asserted-by":"crossref","unstructured":"Gago-Dominguez M, Matabuena M, Redondo C, Patel S, Carracedo A, Ponte S et al. Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions. Sci Rep. 2020;10(1):13203. 2020.","DOI":"10.1038\/s41598-020-70077-z"},{"issue":"1","key":"15197_CR20","doi-asserted-by":"publisher","first-page":"7961568","DOI":"10.1155\/2020\/7961568","volume":"2020","author":"C Jiang","year":"2020","unstructured":"Jiang C, Lu Y, Zhang S, Huang Y. Systemic Immune-Inflammation index is superior to neutrophil to lymphocyte ratio in prognostic assessment of breast cancer patients undergoing neoadjuvant chemotherapy. Biomed Res Int. 2020;2020(1):7961568.","journal-title":"Biomed Res Int"},{"issue":"1","key":"15197_CR21","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1038\/s41598-024-63318-y","volume":"14","author":"M-F Wang","year":"2024","unstructured":"Wang M-F, Cai J-R, Xia H. Chu X-f. Predictive efficacy of the preoperative neutrophil\u2013lymphocyte ratio in lymph node metastasis of cN0 hormone receptor-positive breast cancer. Sci Rep. 2024;14(1):14216.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"15197_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3121\/cmr.2008.825","volume":"7","author":"AA Onitilo","year":"2009","unstructured":"Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009;7(1\u20132):4\u201313.","journal-title":"Clin Med Res"},{"issue":"22","key":"15197_CR23","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.22.02864","volume":"41","author":"AC Wolff","year":"2023","unstructured":"Wolff AC, Somerfield MR, Dowsett M, Hammond MEH, Hayes DF, McShane LM, et al. Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American pathologists guideline update. J Clin Oncol. 2023;41(22):3867\u201372.","journal-title":"J Clin Oncol"},{"key":"15197_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"J-L Ethier","year":"2017","unstructured":"Ethier J-L, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19:1\u201313.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"15197_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.18632\/oncotarget.13714","volume":"8","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Si W, Sun Q, Qin B, Zhao W, Yang J. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer. Oncotarget. 2016;8(1):1023.","journal-title":"Oncotarget"},{"key":"15197_CR26","unstructured":"Cheng HW, Wang T, Yu GC, Xie LY, Shi B. Prognostic role of the systemic immuneinflammation index and pan-immune inflammation value for outcomes of breast cancer: a systematic review and meta-analysis.\u00a0Eur Rev Med Pharmacol Sci. 2024;28(1)."},{"key":"15197_CR27","doi-asserted-by":"crossref","unstructured":"Nishida A, Andoh A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells. 2025;14(7):488.","DOI":"10.3390\/cells14070488"},{"issue":"1","key":"15197_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/imr.12459","volume":"273","author":"KL Singel","year":"2016","unstructured":"Singel KL, Segal BH. Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. Immunol Rev. 2016;273(1):329\u201343.","journal-title":"Immunol Rev"},{"issue":"1","key":"15197_CR29","first-page":"52","volume":"32","author":"D Gautam","year":"2025","unstructured":"Gautam D, Clarke EM, Roweth HG, Smith MR, Battinelli EM. Platelets and Circulating (tumor) cells: partners in promoting metastatic cancer. Curr Opin Hematol. 2025;32(1):52\u201360.","journal-title":"Curr Opin Hematol"},{"key":"15197_CR30","doi-asserted-by":"crossref","unstructured":"Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.\u00a0Breast Cancer Res. 2017;19(1):2.","DOI":"10.1186\/s13058-016-0794-1"},{"key":"15197_CR31","unstructured":"Singh UP, Srivastava V, Siddiqui AA, Verma K, Pretreatment nlr as a biomarker, and it\u2019s correlation with breast cancer staging. : a prospective observational study. International Journal of Scientific Research. 2023."},{"key":"15197_CR32","doi-asserted-by":"crossref","unstructured":"Faria SS, Giannarelli D, Cordeiro de Lima VC, Anwar SL, Casadei C, De Giorgi U, et al. Development of a prognostic model for early breast cancer integrating neutrophil to lymphocyte ratio and clinical-pathological characteristics. The Oncologist. 2024;29(4):e447-54.","DOI":"10.1093\/oncolo\/oyad303"},{"key":"15197_CR33","doi-asserted-by":"crossref","unstructured":"Wang S, Wang Y, Zhuang J, Wu Y, Shi W, Wang L. Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer. PLoS One. 2023;18(9):e0290905.","DOI":"10.1371\/journal.pone.0290905"},{"key":"15197_CR34","doi-asserted-by":"crossref","unstructured":"Liang X, Yao S, Lu P, Ma Y, Xu H, Yin Z, et al. The prognostic value of new index (LANR) composed of pre-operative lymphocytes, albumin, and neutrophils in patients with resectable colorectal cancer.\u00a0Front\u00a0Oncol. 2021;11:610264.","DOI":"10.3389\/fonc.2021.610264"},{"key":"15197_CR35","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhuang J, Wang S, Wu Y, Chen L. The prognostic value of preoperative neoindices consisting of lymphocytes, neutrophils and albumin (LANR) in operable breast cancer: a retrospective study. PeerJ. 2024 May 15;12:e17382.","DOI":"10.7717\/peerj.17382"},{"issue":"30","key":"15197_CR36","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.2217\/fon-2022-0589","volume":"18","author":"X Zhang","year":"2022","unstructured":"Zhang X, Tan X, Li J, Wei Z. Relationship between certain hematological parameters and risk of breast cancer. Future Oncol. 2022;18(30):3409\u201317.","journal-title":"Future Oncol"},{"key":"15197_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/03936155221118098","volume":"37","author":"Z Gong","year":"2022","unstructured":"Gong Z, Xin R, Li L, Lv L, Wu X. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis. Int J Biol Mark. 2022;37:339\u201348.","journal-title":"Int J Biol Mark"},{"key":"15197_CR38","doi-asserted-by":"crossref","unstructured":"Wiranata S, Adiputra P, Lestari A, Prabawa I, Supadmanaba I. Platelet lymphocyte ratio (PLR) related with clinicopathological characteristics of Balinese women breast cancer patient. Annals of Oncology. 2019.","DOI":"10.1093\/annonc\/mdz343.124"},{"key":"15197_CR39","doi-asserted-by":"crossref","unstructured":"Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.\u00a0World J Surg Oncol. 2020;18(1):197.","DOI":"10.1186\/s12957-020-01974-w"},{"key":"15197_CR40","doi-asserted-by":"crossref","unstructured":"Zhang Y, Sun Y, Zhang Q. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer cell international. 2020;20(1):224.","DOI":"10.1186\/s12935-020-01308-6"},{"key":"15197_CR41","doi-asserted-by":"crossref","unstructured":"Ciurescu S, Tomescu L, \u0218erban D, Nicolae N, Nan G, Buciu V, et al. The Prognostic Value of Systemic Inflammation Index in Breast Cancer: A Retrospective Study in Western Romania. Journal of Clinical Medicine. 2025;14(4):1081.","DOI":"10.3390\/jcm14041081"},{"key":"15197_CR42","doi-asserted-by":"crossref","unstructured":"Y\u0131lmaz H, Ni\u011fdelio\u011flu B, Ayta\u00e7 A, Turan M, Oktay E, Yersal O et al. The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4\/6 inhibitors. Future Oncol. 2022.","DOI":"10.2217\/fon-2022-0464"},{"key":"15197_CR43","doi-asserted-by":"crossref","unstructured":"Liu R, Shen Y, Cui J, Ma W, Wang J, Chen C, Wang W. Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors. Frontiers in Immunology. 2024 Dec 6;15:1454393.","DOI":"10.3389\/fimmu.2024.1454393"},{"key":"15197_CR44","doi-asserted-by":"crossref","unstructured":"Liu L, Zhang BB, Li YZ, Huang WJ, Niu Y, Jia QC, Wang W, Yuan JR, Miao SD, Wang RT, Wang GY. Preoperative glucose-to-lymphocyte ratio predicts survival in cancer. Frontiers in Endocrinology. 2024 Mar 4;15:1284152.","DOI":"10.3389\/fendo.2024.1284152"},{"key":"15197_CR45","doi-asserted-by":"crossref","unstructured":"Ding W, Ye D, Chen H, Lin Y, Li Z, Tu C. Clinicopathological differences and survival benefit in ER+\/PR+\/HER2\u2009+\u2009vs ER+\/PR-\/HER2\u2009+\u2009breast cancer subtypes. Breast Cancer. 2024.","DOI":"10.1007\/s12282-023-01538-2"},{"key":"15197_CR46","doi-asserted-by":"crossref","unstructured":"Zhou Y, Guo X, Shen L, Liu K, Sun Q, Wang Y, Wang H, Fu W, Yao Y, Wu S, Chen H. Predictive significance of systemic immune-inflammation index in patients with breast cancer: A retrospective cohort study. OncoTargets and Therapy. 2023 Dec 31:939-60.","DOI":"10.2147\/OTT.S434193"},{"key":"15197_CR47","first-page":"2227","volume":"18","author":"\u00d6 Yersal","year":"2017","unstructured":"Yersal \u00d6, \u00c7etink\u00fcnar S, Aktimur R, Aziret M, \u00d6zda\u015f S, Erdem H, et al. Neutrophil\/Lymphocyte and Platelet\/Lymphocyte ratios are not different among breast cancer subtypes. Asian Pac J Cancer Prevention: APJCP. 2017;18:2227\u201331.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"key":"15197_CR48","doi-asserted-by":"crossref","unstructured":"Yilmaz S, Aykota MR, Sari T, Karakaya YA, Erdem E. Simple peripheral blood cell parameters: neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios do not determine breast cancer subtypes. Indian Journal of Surgery. 2021 Jun;83(Suppl 2):382-7.","DOI":"10.1007\/s12262-020-02256-1"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15197-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:31:07Z","timestamp":1767000667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15197"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15197-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by the Iran University of Medical Sciences research ethics committee with the ethics code: IR.IUMS.REC.1403.588.It is hereby announced that informed consent has been obtained from all the participants to conduct the study and the personal information of the patients will not be disclosed in any way. Also, all experiments on human tissue samples were performed in accordance with relevant guidelines and regulations. The patient consent form is the official form of Rasool Akram Hospitals and is available for all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1886"}}